Joint Ventures: Aiming for Targeted First-Line Therapy in Early RA at EULAR 2026ByJack Arnold, MBBS, MRCP, PhD,Laurence Duquenne, MD, PhDJune 23rd 2026Laurence Duquenne, MD, PhD, joins Joint Ventures to discuss the TEEMS trial and T-cell stratification.